KMT2D.md
... ...
@@ -2,6 +2,8 @@
2 2
bibliography: 'morinlab.bib'
3 3
csl: 'NLM.csl'
4 4
link-citations: true
5
+nocite: |
6
+ @rossiCodingGenomeSplenic2012, @deschGenotypingCirculatingTumor2020, @morinFrequentMutationHistonemodifying2011, @beaLandscapeSomaticMutations2013
5 7
---
6 8
[[_TOC_]]
7 9
... ...
@@ -17,14 +19,7 @@ Mutations were later described in MCL in 2013 by Bea et al.[@beaLandscapeSomatic
17 19
18 20
## Relevance tier by entity
19 21
20
-|Entity|Tier|Description |
21
-|:------:|:----:|--------------------------|
22
-|![MZL](images/icons/MZL_tier1.png)|1|high-confidence MZL gene[@rossiCodingGenomeSplenic2012]|
23
-|![PMBL](images/icons/PMBL_tier2.png)|2|relevance in PMBL/cHL/GZL not firmly established[@deschGenotypingCirculatingTumor2020]|
24
-|![FL](images/icons/FL_tier1.png) |1 |high-confidence FL gene [@morinFrequentMutationHistonemodifying2011]|
25
-|![DLBCL](images/icons/DLBCL_tier1.png) |1 |high-confidence DLBCL gene[@morinFrequentMutationHistonemodifying2011]|
26
-|![BL](images/icons/BL_tier1.png) |1 |high-confidence BL gene |
27
-|![MCL](images/icons/MCL_tier1.png) |1 |high-confidence MCL gene [@beaLandscapeSomaticMutations2013]|
22
+[[include:table1_KMT2D]]
28 23
29 24
## Mutation incidence in large patient cohorts (GAMBL reanalysis)
30 25